Cholesterol biosynthesis and metabolism
- 1 April 1992
- journal article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 6 (2) , 103-110
- https://doi.org/10.1007/bf00054556
Abstract
Cholesterol plays an essential role in cell membrane synthesis and in cell growth and differentiation. In mammalian cells, cholesterol can be synthesized from acetate precursors or taken up from dietary or exogenous sources. The major catabolic route for disposal of cholesterol involves conversion into excretable bile acids. The maintenance of cholesterol homeostasis is influenced and carefully controlled by multiple feedback mechanisms. The key regulatory targets of these feedback mechanisms are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase in cholesterol biosynthesis, the low-density lipoprotein (LDL) receptor in cholesterol uptake, and cholesterol 7α-hydroxy-lase in cholesterol catabolism. The elucidation of regulatory mechanisms in cholesterol metabolism has been greatly facilitated by the discovery of a new class of lipid-lowering drugs, the HMG-CoA reductase inhibitors. In addition to proving therapeutically useful in the treatment of hypercholesterolemia, these drugs have revealed novel regulatory steps in cholesterol metabolism and several new targets for future drug development. This manuscript reviews recent developments in the cholesterol biosynthetic pathway and the regulatory mechanisms that maintain cholesterol homeostasis.Keywords
This publication has 65 references indexed in Scilit:
- Structure of the rat gene encoding cholesterol 7.alpha.-hydroxylaseBiochemistry, 1990
- GTP binding and growth controlCurrent Opinion in Cell Biology, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Molecular cloning of cDNA for cholesterol 7α‐hydroxylase from rat liver microsomesFEBS Letters, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Regulation of Cholesterol BiosynthesisAnnual Review of Nutrition, 1986
- Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzymeCell, 1985
- The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNACell, 1984
- Regulation of cholesterol metabolism in man and in other speciesJournal of Molecular Medicine, 1984
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976